TD Cowen analyst Bryan Bergin lowered the firm’s price target on Endava to $42 from $46 and keeps a Buy rating on the shares. The firm said 3Q was a mixed bag andthe company revised its 4Q organic view marking the low-end of its prior guide. Still, a message of stability and a more conservative guide posture were well-received.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAVA: